PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MXCT.L vs. ISRG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between MXCT.L and ISRG is 0.09, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.1

Performance

MXCT.L vs. ISRG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in MaxCyte Inc (MXCT.L) and Intuitive Surgical, Inc. (ISRG). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2025February
-2.24%
23.25%
MXCT.L
ISRG

Key characteristics

Sharpe Ratio

MXCT.L:

-0.22

ISRG:

2.19

Sortino Ratio

MXCT.L:

0.04

ISRG:

3.36

Omega Ratio

MXCT.L:

1.01

ISRG:

1.42

Calmar Ratio

MXCT.L:

-0.16

ISRG:

6.69

Martin Ratio

MXCT.L:

-0.69

ISRG:

19.71

Ulcer Index

MXCT.L:

18.24%

ISRG:

2.90%

Daily Std Dev

MXCT.L:

56.27%

ISRG:

26.15%

Max Drawdown

MXCT.L:

-82.86%

ISRG:

-82.25%

Current Drawdown

MXCT.L:

-73.22%

ISRG:

-2.44%

Fundamentals

Market Cap

MXCT.L:

£347.17M

ISRG:

$212.41B

EPS

MXCT.L:

-£0.27

ISRG:

$6.49

Total Revenue (TTM)

MXCT.L:

£29.94M

ISRG:

$8.35B

Gross Profit (TTM)

MXCT.L:

£25.12M

ISRG:

$5.63B

EBITDA (TTM)

MXCT.L:

-£35.04M

ISRG:

$2.76B

Returns By Period

In the year-to-date period, MXCT.L achieves a 1.23% return, which is significantly lower than ISRG's 14.10% return.


MXCT.L

YTD

1.23%

1M

-16.75%

6M

5.81%

1Y

-12.53%

5Y*

16.19%

10Y*

N/A

ISRG

YTD

14.10%

1M

0.49%

6M

23.52%

1Y

57.29%

5Y*

23.89%

10Y*

26.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

MXCT.L vs. ISRG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MXCT.L
The Risk-Adjusted Performance Rank of MXCT.L is 3232
Overall Rank
The Sharpe Ratio Rank of MXCT.L is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of MXCT.L is 3232
Sortino Ratio Rank
The Omega Ratio Rank of MXCT.L is 3232
Omega Ratio Rank
The Calmar Ratio Rank of MXCT.L is 3434
Calmar Ratio Rank
The Martin Ratio Rank of MXCT.L is 3030
Martin Ratio Rank

ISRG
The Risk-Adjusted Performance Rank of ISRG is 9595
Overall Rank
The Sharpe Ratio Rank of ISRG is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of ISRG is 9393
Sortino Ratio Rank
The Omega Ratio Rank of ISRG is 9191
Omega Ratio Rank
The Calmar Ratio Rank of ISRG is 9999
Calmar Ratio Rank
The Martin Ratio Rank of ISRG is 9797
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

MXCT.L vs. ISRG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for MaxCyte Inc (MXCT.L) and Intuitive Surgical, Inc. (ISRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MXCT.L, currently valued at -0.15, compared to the broader market-2.000.002.004.00-0.152.03
The chart of Sortino ratio for MXCT.L, currently valued at 0.17, compared to the broader market-6.00-4.00-2.000.002.004.006.000.173.17
The chart of Omega ratio for MXCT.L, currently valued at 1.02, compared to the broader market0.501.001.502.001.021.40
The chart of Calmar ratio for MXCT.L, currently valued at -0.11, compared to the broader market0.002.004.006.00-0.116.18
The chart of Martin ratio for MXCT.L, currently valued at -0.50, compared to the broader market-10.000.0010.0020.0030.00-0.5018.14
MXCT.L
ISRG

The current MXCT.L Sharpe Ratio is -0.22, which is lower than the ISRG Sharpe Ratio of 2.19. The chart below compares the historical Sharpe Ratios of MXCT.L and ISRG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
-0.15
2.03
MXCT.L
ISRG

Dividends

MXCT.L vs. ISRG - Dividend Comparison

Neither MXCT.L nor ISRG has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MXCT.L vs. ISRG - Drawdown Comparison

The maximum MXCT.L drawdown since its inception was -82.86%, roughly equal to the maximum ISRG drawdown of -82.25%. Use the drawdown chart below to compare losses from any high point for MXCT.L and ISRG. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-75.57%
-2.44%
MXCT.L
ISRG

Volatility

MXCT.L vs. ISRG - Volatility Comparison

MaxCyte Inc (MXCT.L) has a higher volatility of 10.94% compared to Intuitive Surgical, Inc. (ISRG) at 6.56%. This indicates that MXCT.L's price experiences larger fluctuations and is considered to be riskier than ISRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
10.94%
6.56%
MXCT.L
ISRG

Financials

MXCT.L vs. ISRG - Financials Comparison

This section allows you to compare key financial metrics between MaxCyte Inc and Intuitive Surgical, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. MXCT.L values in GBp, ISRG values in USD
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab